[Resistance of Plasmodium falciparum to fansidar, quinine and tetracycline].
D000293:Adolescent; D002738:Chloroquine / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004338:Drug Combinations / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D008288:Malaria / Q000188:drug therapy / Q000469:parasitology; D010963:Plasmodium falciparum / Q000187:drug effects*; D011739:Pyrimethamine / Q000494:pharmacology*; D011803:Quinine / Q000494:pharmacology*; D013413:Sulfadoxine / Q000494:pharmacology*; D013424:Sulfanilamides / Q000494:pharmacology*; D013752:Tetracycline / Q000494:pharmacology*
D004338:Drug Combinations; D013424:Sulfanilamides; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D002738:Chloroquine; D011803:Quinine; D013752:Tetracycline; D011739:Pyrimethamine
Resisténcia do plasmodium falciparum ao fansidar, quinina e tetraciclina.